# Intranasal Versus Nebulized Midazolam in Behaviuor Modification of Preschool Children Undergoing Dental Treatment

> **NCT05883150** · PHASE2,PHASE3 · COMPLETED · sponsor: **Nourhan M.Aly** · enrollment: 68 (actual)

## Conditions studied

- Dental Sedation

## Interventions

- **DRUG:** Nebulized Midazolam
- **DRUG:** Intranasal Midazolam

## Key facts

- **NCT ID:** NCT05883150
- **Lead sponsor:** Nourhan M.Aly
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-10
- **Primary completion:** 2023-08-30
- **Final completion:** 2023-08-30
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2023-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05883150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05883150, "Intranasal Versus Nebulized Midazolam in Behaviuor Modification of Preschool Children Undergoing Dental Treatment". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05883150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*